The FDA-approved Natural Product Dihydroergocristine Reduces the Production of the Alzheimer’s Disease Amyloid-Β Peptides

Scientific Reports - United Kingdom
doi 10.1038/srep16541
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2015English

Simplified Β-Amyloid Peptides for Safer Alzheimer’s Vaccines Development

Human Vaccines
2010English

Amyloid‐β Oligomers in Cellular Models of Alzheimer’s Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2020English

The A673T Mutation in the Amyloid Precursor Protein Reduces the Production of Β-Amyloid Protein From Its Β-Carboxyl Terminal Fragment in Cells

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2015English

P‐glycoprotein: A Role in the Export of Amyloid‐β in Alzheimer’s Disease?

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2019English

Pioglitazone Reduces Β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Alzheimer’s Disease: How Metal Ions Define Β-Amyloid Function

Coordination Chemistry Reviews
Inorganic ChemistryMaterials ChemistryTheoretical ChemistryPhysical
2017English

Oligomeric Amyloid Β Induces IL-1β Processing via Production of ROS: Implication in Alzheimer’s Disease

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy